Home | DAIC

Statistically significant reduction in the risk for the primary outcome on Day 27

New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at ACC23

March 4, 2023 - Lexicon Pharmaceuticals, Inc. announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...

March 04, 2023

Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed therapy for pulmonary embolism

News | Artificial Intelligence

Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial

March 4, 2023 — Viz.ai, a leader in AI-powered disease detection and care coordination, announced it will use its VizTM ...

March 04, 2023

News | ACC

CLEAR Trial Reported at ACC23 Finds Bempedoic Acid Lowers LDL Cholesterol, Reduces Risk of Serious Cardiovascular Outcomes in Statin-Intolerant Patients

March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse ...

March 04, 2023

Sponsored Content

Feature | Thrombectomy Devices

Redefining PE and VTE Intervention

Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...

June 01, 2026

Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)

News | Structural Heart

New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation

March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a ...

March 04, 2023

News | ACC

GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC

March 4, 2023 — GE HealthCare will present its latest technologies and innovations for use during the critical planning ...

March 04, 2023

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference

News | ACC

Four New Studies Featuring Zio by iRhythm to be Presented at ACC.23/WCC

March 3, 2023 — iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions that ...

March 03, 2023

Sponsored Content

Feature | Cardiac Imaging

Providing Clarity into CAD

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

March 13, 2026

Machine learning can be used to help clinicians with early diagnosis

News | Heart Failure

Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease

March 3, 2023 — Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart ...

March 03, 2023

News | FFR Technologies

CathWorks to Present Outcomes from International Real-World FFRangio Registry to be Presented at ACC 2023

March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...

March 03, 2023

Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more than double a person’s likelihood of developing cardiovascular issues, according to a study being presented at the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, taking place March 4-6, 2023, in New Orleans, LA.

News | Coronavirus (COVID-19)

ACC23 Study Finds Long COVID More Than Doubles Risk of Developing New Cardiac Symptoms

March 3, 2023 — Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more ...

March 03, 2023

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Primary Results from RADIANCE II Trial Published in JAMA and Results of Pooled Analysis from Three RADIANCE Studies Published in JAMA Cardiology

News | Renal Denervation

ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

March 2, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that primary ...

March 02, 2023

Philips Ultrasound Compact System 5500 CV adds to Philips’ cardiology portfolio bringing diagnostic quality cardiac imaging to the patient bedside

News | ACC

Philips Showcases Comprehensive Cardiology Portfolio at ACC23

March 2, 2023 — Royal Philips is showcasing enhancements to its cardiology portfolio at the Annual Scientific Session & ...

March 02, 2023

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: A Look at the Hot Topics from February

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

March 01, 2023

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Single Intra-Myocardial Intervention with Rexlemestrocel-L Reduced Cardiovascular Death, Myocardial Infarction or Stroke Over Mean Follow-Up of 30 Months in High-Risk Patients with Chronic Heart Failure

News | Ventricular Assist Devices (VAD)

DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology

March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...

March 01, 2023

System Leverages Next Generation DeepOCTÔ Technology and Near Infrared Spectroscopy to Optimize Coronary Stent Placement in the Cardiac Catheterization Lab

News | Cath Lab

SpectraWAVE Secures 510(k) Clearance of HyperVue Intravascular Imaging System

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

March 01, 2023

33-year-old, low risk of acute coronary syndrome, presents to off-hour ED with acute chest pain

News | Computed Tomography (CT)

Coronary CTA for Acute Chest Pain Emergencies: Single- vs. Dual-Source Scanners

March 1, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), using a ...

March 01, 2023